Sign in
Taking people in Hong KongNo phase

Program to prevent insomnia in young people at risk of sleep problems

Tests a sleep-focused talking program against health education in young people at risk of insomnia.

Key facts

Who runs it
Chinese University of Hong Kong
Where
Shatin, Hong KongSee the site
Trial code
Registry title
Prevention of Insomnia in At-risk Youth
Status
Recruiting
People taking part
204 people, planned
Started
1 Jul 2022
Planned end
15 Jul 2026
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Insomnia prevention program
  • General health education
Record updated
10 July 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for young people aged 15-24 years who have mild sleep problems and a parent with insomnia. It compares a group sleep program meant to prevent insomnia with general health education.

Age
15 to 24 years
Sex
All sexes
Disease stage
Mild (subclinical) insomnia symptoms: at least once a month but less than 3 times a week in the past one month. At least one biological parent has or had insomnia disorder.
Earlier treatment
People currently receiving any structured psychotherapy (talking therapy) cannot join.

Main reasons for not taking part

  • Current or past brain or mental health disorder
  • A major medical condition, or medicine that may affect sleep
  • A diagnosed sleep disorder, such as insomnia, delayed sleep phase, narcolepsy or restless leg syndrome
  • Serious suicidal thoughts with a plan, or a suicide attempt
  • Hearing or speech problems, or a flight across time zones in the past 3 months or during the study

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • Youth aged between 15-24 years (as defined by WHO)
  • Written informed consent of participation into the study is given by youth and his/her parents if under 18 years old; In addition, individual assent will also be obtained for subjects under age 18 years old
  • Have subclinical insomnia symptoms (at least once a month but less than 3 times/week in the past one month)
  • At least one of the biological parents with current or lifetime history of insomnia disorder as defined by DSM-V diagnostic criteria

Who cannot take part

  • Currently receiving any structured psychotherapy
  • A current or past history of neuropsychiatric disorder(s)
  • A prominent medical condition or taking medication with potential side effects that may influence sleep quantity and quality
  • Having a diagnosed sleep disorder that may potentially contribute to the disruption of sleep quantity and quality as ascertained by both Structured Diagnostic Interview for Sleep patterns and Disorders (DISP) such as insomnia, delayed sleep phase and narcolepsy, restless leg syndrome
  • Having a clinically significant suicidality (presence of suicidal ideation with a plan or an attempt)
  • With hearing or speech deficit
  • Trans-meridian flight in the past 3 months and during the study

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 15 and 24 years old?

Where in Hong Kong

  • Department of PsychiatryShatin, Hong KongContact: NGAN YIN CHAN, PhDTaking people

About the trial

What the trial wants to find out

This study aims to conduct a randomized controlled trial in comparing cognitive behavioral insomnia prevention program with the active control group in youths who are at risk of insomnia. The results of this study will allow us to take this potential efficacious prevention program to scale and reduce the associated burden of insomnia in the future.

The 2 groups in the trial

  • Insomnia prevention programTreatment being tested

    The preventive program has been developed and modified as based on the evidence-based CBT-I insomnia treatment. Active intervention group will be conducted in group size with 6-8 subjects who are from the same education level (i.e. secondary vs university). Youths in the intervention group will receive 4 weekly insomnia prevention program conducted by the sleep therapists who has received training in conducting CBT-I under close supervision of sleep experts. Each session will last for about 60-90 mins.

  • General health educationExisting treatment, for comparison

    In order to control for placebo effect and other non-specific factors such as contact time, youths in the control group will be provided with group-based general health education with same dosage (4 weeks) as intervention group. Modules will contain information about general well-being, diet, nutrition, and activity. It is expected that this health education will be an active control group to account for most of the non-specific effects including time, attention, therapist, and peer support.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Prevention of Insomnia in At-risk Youth: A Randomized Controlled Trial Comparing Cognitive Behavioural Prevention Programme for Insomnia With Active Control Condition
Plain-language title
Program to prevent insomnia in young people at risk of sleep problemsGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Fit questions
Built from NCT05451524, who can take part
Record updated
10 July 2025